US regulator clears Merck’s lung therapy after ‘significant’ results
HQ Team March 27, 2024: The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to
HQ Team March 27, 2024: The US regulator, the Food and Drug Administration, has approved Winrevair therapy of Merck & Co., Inc., to
HQ Team March 26, 2024: The US regulator, the Food and Drug Administration plans to ban electrical stimulation devices due to “unreasonable and
HQ Team March 25, 2024: Novo Nordisk, one of the world’s most valuable companies, will acquire Germany-based Cardior Pharmaceuticals, a firm that specialises
HQ Team March 23, 2024: Researchers in the UK have won a grant of $2.14 million (€1.98 million) from the Cancer Research UK
HQ Team March 22, 2024: A recent study titled “Cryptic diversity of cellulose-degrading gut bacteria in industrialized humans” says that urban dwellers are
HQ Team March 21, 2024: Richard Slayman, 62, of Weymouth, Massachusetts, became the first human to receive a kidney from a genetically modified
HQ Team March 21, 2024: An abnormal protein called phosphorylated α-synuclein present in the nerve fibres in the skin — the pathological hallmark
HQ Team March 21, 2024: Noland Arbaugh, 29, the first human to receive Neuralink’s brain implant, was able to play online chess and
HQ Team March 21, 2024: A panel consisting of Nobel laureates, former presidents and prime ministers have urged global negotiators of WHO member